Earley insisted in his testimony that AEG Live's funding did not influence the conclusions of his study or his testimony in the trial. But the Jackson lawyer hammered the doctor about the lack of disclosure to the scientific journal and his collaborator that he was being paid to be an expert witness in the trial.
He informed them that he was doing research for the company, but the trial aspect was "irrelevant," Earley said.
"It's irrelevant to health care professionals," he said. "It wouldn't affect their understanding of the paper."